Skip to Content

  • Search

View Additional Section Content

CL-PTL-119- VITAL- A Randomized, Double-Blind, Placebo-Controlled Phase II/III Trial of Vigil Augmented Autologous Tumor Cell Immunotherapy in Subjects with Stage III/IV Ovarian Cancer in Clinical Complete Response Following Surgery and Primary Chemotherapy (VITAL)

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/record/NCT02346747?term=fang&rank=9

Principal Investigator(s)
Parviz Hanjani, M.D.

Clinical Trial Categories

  • Ovarian Cancer
Contact
Hanjani Institute for Gynecologic Oncology at 215-885-0220

Location

  • Hanjani Institute for Gynecologic Oncology
    The Rosenfeld Cancer Center
    1200 Old York Rd, AMH - 1 Widener
    Abington, PA 19001
    Office: 215-885-0220
    Fax: 215-576-0740

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details